Grant A. Krafft - Publications

Affiliations: 
Northwestern University, Evanston, IL 
Area:
Neuroscience Biology

43/157 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Krafft GA, Jerecic J, Siemers E, Cline EN. ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer's Disease. Frontiers in Neuroscience. 16: 848215. PMID 35557606 DOI: 10.3389/fnins.2022.848215  0.373
2018 Wang X, Kastanenka KV, Arbel-Ornath M, Commins C, Kuzuya A, Lariviere AJ, Krafft GA, Hefti F, Jerecic J, Bacskai BJ. An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging. Scientific Reports. 8: 4634. PMID 29545579 DOI: 10.1038/S41598-018-22979-2  0.395
2014 Goure WF, Krafft GA, Jerecic J, Hefti F. Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics. Alzheimer's Research & Therapy. 6: 42. PMID 25045405 DOI: 10.1186/Alzrt272  0.526
2013 Hefti F, Goure WF, Jerecic J, Iverson KS, Walicke PA, Krafft GA. The case for soluble Aβ oligomers as a drug target in Alzheimer's disease. Trends in Pharmacological Sciences. 34: 261-6. PMID 23582316 DOI: 10.1016/J.Tips.2013.03.002  0.458
2013 Krafft G, Hefti F, Goure W, Jerecic J, Iverson K, Walicke P. O2-06-03: ACU-193: A candidate therapeutic antibody that selectively targets soluble beta-amyloid oligomers Alzheimer's & Dementia. 9: P326-P326. DOI: 10.1016/J.Jalz.2013.04.166  0.417
2010 Krafft GA, Klein WL. ADDLs and the signaling web that leads to Alzheimer's disease. Neuropharmacology. 59: 230-42. PMID 20650286 DOI: 10.1016/J.Neuropharm.2010.07.012  0.49
2010 Gandy S, Simon AJ, Steele JW, Lublin AL, Lah JJ, Walker LC, Levey AI, Krafft GA, Levy E, Checler F, Glabe C, Bilker WB, Abel T, Schmeidler J, Ehrlich ME. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Annals of Neurology. 68: 220-30. PMID 20641005 DOI: 10.1002/Ana.22052  0.328
2009 Zhao WQ, Lacor PN, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL. Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric a{beta}. The Journal of Biological Chemistry. 284: 18742-53. PMID 19406747 DOI: 10.1074/Jbc.M109.011015  0.33
2008 Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL. Amyloid beta oligomers induce impairment of neuronal insulin receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 246-60. PMID 17720802 DOI: 10.1096/Fj.06-7703Com  0.386
2007 Look GC, Jerecic J, Cherbavaz DB, Pray TR, Breach JC, Crosier WJ, Igoudin L, Hironaka CM, Lowe RM, McEntee M, Ruslim-Litrus L, Wu HM, Zhang S, Catalano SM, Goure WF, ... ... Krafft GA, et al. Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease. Current Alzheimer Research. 4: 562-7. PMID 18220523 DOI: 10.2174/156720507783018271  0.45
2007 Lambert MP, Velasco PT, Chang L, Viola KL, Fernandez S, Lacor PN, Khuon D, Gong Y, Bigio EH, Shaw P, De Felice FG, Krafft GA, Klein WL. Monoclonal antibodies that target pathological assemblies of Abeta. Journal of Neurochemistry. 100: 23-35. PMID 17116235 DOI: 10.1111/J.1471-4159.2006.04157.X  0.5
2006 Catalano SM, Dodson EC, Henze DA, Joyce JG, Krafft GA, Kinney GG. The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. Current Topics in Medicinal Chemistry. 6: 597-608. PMID 16712494 DOI: 10.2174/156802606776743066  0.539
2005 Krafft G. [AM-03]: Oligomers/Protofibrials/ADDLs Alzheimer's & Dementia. 1: S1-S1. DOI: 10.1016/j.jalz.2005.06.030  0.353
2004 Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10191-200. PMID 15537891 DOI: 10.1523/Jneurosci.3432-04.2004  0.503
2003 Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT, Jones BW, Fernandez SJ, Lacor PN, Horowitz P, Finch CE, Krafft GA, Klein WL. Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry. 42: 12749-60. PMID 14596589 DOI: 10.1021/Bi030029Q  0.472
2003 Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proceedings of the National Academy of Sciences of the United States of America. 100: 10417-22. PMID 12925731 DOI: 10.1073/Pnas.1834302100  0.521
2003 Stine WB, Dahlgren KN, Krafft GA, LaDu MJ. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. The Journal of Biological Chemistry. 278: 11612-22. PMID 12499373 DOI: 10.1074/Jbc.M210207200  0.493
2003 Kim HJ, Chae SC, Lee DK, Chromy B, Lee SC, Park YC, Klein WL, Krafft GA, Hong ST. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 118-20. PMID 12424218 DOI: 10.1096/Fj.01-0987Fje  0.628
2002 Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. The Journal of Biological Chemistry. 277: 32046-53. PMID 12058030 DOI: 10.1074/Jbc.M201750200  0.474
2002 Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, Trommer BL. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Research. 924: 133-40. PMID 11750898 DOI: 10.1016/S0006-8993(01)03058-X  0.47
2002 Morgan TE, Krafft GA. Chapter 4. Emerging themes in Alzheimer's disease research: Paradigm shift in drug discovery Annual Reports in Medicinal Chemistry. 37: 31-40. DOI: 10.1016/S0065-7743(02)37005-2  0.307
2001 Lambert MP, Viola KL, Chromy BA, Chang L, Morgan TE, Yu J, Venton DL, Krafft GA, Finch CE, Klein WL. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. Journal of Neurochemistry. 79: 595-605. PMID 11701763 DOI: 10.1046/J.1471-4159.2001.00592.X  0.49
2001 Klein WL, Krafft GA, Finch CE. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends in Neurosciences. 24: 219-24. PMID 11250006 DOI: 10.1016/S0166-2236(00)01749-5  0.531
1998 Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences of the United States of America. 95: 6448-53. PMID 9600986 DOI: 10.1073/Pnas.95.11.6448  0.492
1998 Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Research. 785: 195-206. PMID 9518610 DOI: 10.1016/S0006-8993(97)01318-8  0.517
1997 Berg MM, Krafft GA, Klein WL. Rapid impact of beta-amyloid on paxillin in a neural cell line. Journal of Neuroscience Research. 50: 979-89. PMID 9452012 DOI: 10.1002/(Sici)1097-4547(19971215)50:6<979::Aid-Jnr8>3.0.Co;2-A  0.472
1997 Sayre LM, Zagorski MG, Surewicz WK, Krafft GA, Perry G. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. Chemical Research in Toxicology. 10: 518-26. PMID 9168248 DOI: 10.1021/Tx970009N  0.485
1996 Zhang C, Qiu HE, Krafft GA, Klein WL. A beta peptide enhances focal adhesion kinase/Fyn association in a rat CNS nerve cell line. Neuroscience Letters. 211: 187-90. PMID 8817572 DOI: 10.1016/0304-3940(96)12761-0  0.456
1996 Roher AE, Chaney MO, Kuo YM, Webster SD, Stine WB, Haverkamp LJ, Woods AS, Cotter RJ, Tuohy JM, Krafft GA, Bonnell BS, Emmerling MR. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. The Journal of Biological Chemistry. 271: 20631-5. PMID 8702810 DOI: 10.1074/Jbc.271.34.20631  0.483
1996 Zhang C, Qiu HE, Krafft GA, Klein WL. Protein kinase C and F-actin are essential for stimulation of neuronal FAK tyrosine phosphorylation by G-proteins and amyloid beta protein. Febs Letters. 386: 185-8. PMID 8647278 DOI: 10.1016/0014-5793(96)00435-8  0.358
1996 Stine WB, Snyder SW, Ladror US, Wade WS, Miller MF, Perun TJ, Holzman TF, Krafft GA. The Nanometer-scale structure of amyloid-β visualized by atomic force microscopy Protein Journal. 15: 193-203. DOI: 10.1007/Bf01887400  0.381
1995 Sabo S, Lambert MP, Kessey K, Wade W, Krafft G, Klein WL. Interaction of beta-amyloid peptides with integrins in a human nerve cell line. Neuroscience Letters. 184: 25-8. PMID 7739799 DOI: 10.1016/0304-3940(94)11159-G  0.507
1995 Kohnken RE, Ladror US, Wang GT, Holznan TF, Miller BE, Krafft GA. Cathepsin D from Alzheimer's-Diseased and Normal Brains Experimental Neurology. 133: 105-112. PMID 7649217 DOI: 10.1006/Exnr.1995.1013  0.388
1994 Giordano T, Pan JB, Monteggia LM, Holzman TF, Snyder SW, Krafft G, Ghanbari H, Kowall NW. Similarities between beta amyloid peptides 1-40 and 40-1: effects on aggregation, toxicity in vitro, and injection in young and aged rats. Experimental Neurology. 125: 175-82. PMID 8313936 DOI: 10.1006/Exnr.1994.1022  0.443
1994 Snyder SW, Wang GT, Barrett L, Ladror US, Casuto D, Lee CM, Krafft GA, Holzman RB, Holzman TF. Complement C1q does not bind monomeric beta-amyloid. Experimental Neurology. 128: 136-42. PMID 8070518 DOI: 10.1006/Exnr.1994.1121  0.486
1994 Ladror US, Wang GT, Klein WL, Holzman TF, Krafft GA. Potential βPP-processing proteinase activities from alzheimer's and control brain tissues Journal of Protein Chemistry. 13: 357-366. PMID 7986341 DOI: 10.1007/Bf01901691  0.356
1994 Ladror US, Kohnken RE, Wang GT, Manelli AM, Frail DE, Klein WL, Holzman TF, Krafft GA. Evidence against a role for the Kunitz domain in amyloidogenic and secretory processing of the amyloid precursor protein. Journal of Neurochemistry. 63: 2225-30. PMID 7964742 DOI: 10.1046/J.1471-4159.1994.63062225.X  0.459
1994 Zhang C, Lambert MP, Bunch C, Barber K, Wade WS, Krafft GA, Klein WL. Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A beta peptide. The Journal of Biological Chemistry. 269: 25247-50. PMID 7929215  0.404
1994 Pope WB, Lambert MP, Leypold B, Seupaul R, Sletten L, Krafft G, Klein WL. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y. Experimental Neurology. 126: 185-94. PMID 7925819 DOI: 10.1006/Exnr.1994.1057  0.353
1994 Snyder SW, Ladror US, Wade WS, Wang GT, Barrett LW, Matayoshi ED, Huffaker HJ, Krafft GA, Holzman TF. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophysical Journal. 67: 1216-28. PMID 7811936 DOI: 10.1016/S0006-3495(94)80591-0  0.465
1994 Wang GT, Ladror US, Holzman TF, Klein WL, Krafft GA. Cleavage of fluorogenic substrates for APP-processing proteases by human brain extracts. Ca(2+)-substrate interaction is responsible for Ca2+ stimulation of the neural protease activity. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 23: 191-9. PMID 7702708 DOI: 10.1007/Bf02815411  0.367
1994 Lambert MP, Stevens G, Sabo S, Barber K, Wang G, Wade W, Krafft G, Snyder S, Holzman TF, Klein WL. Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells. Journal of Neuroscience Research. 39: 377-85. PMID 7533843 DOI: 10.1002/Jnr.490390404  0.42
1993 Krafft GA. Chapter 6. Perspectives on Amyloid and Alzheimer's Disease: A Critical Review Annual Reports in Medicinal Chemistry. 28: 49-58. DOI: 10.1016/S0065-7743(08)60876-3  0.32
Low-probability matches (unlikely to be authored by this person)
1992 Wang GT, Krafft GA. Automated synthesis of fluorogenic protease substrates: design of probes for alzheimer's disease-associated proteases Bioorganic and Medicinal Chemistry Letters. 2: 1665-1668. DOI: 10.1016/S0960-894X(00)80452-7  0.292
1994 Ladror US, Snyder SW, Wang GT, Holzman TF, Krafft GA. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-β by cathepsin D Journal of Biological Chemistry. 269: 18422-18428. PMID 8034590  0.287
1996 Stine WB, Snyder SW, Ladror US, Wade WS, Miller MF, Perun TJ, Holzman TF, Krafft GA. The Nanometer-scale structure of amyloid-β visualized by atomic force microscopy Protein Journal. 15: 193-203. DOI: 10.1007/BF01887400  0.281
1998 Komano H, Seeger M, Gandy S, Wang GT, Krafft GA, Fuller RS. Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast. The Journal of Biological Chemistry. 273: 31648-51. PMID 9822624 DOI: 10.1074/jbc.273.48.31648  0.268
2008 Kelley NW, Vishal V, Krafft GA, Pande VS. Simulating oligomerization at experimental concentrations and long timescales: A Markov state model approach. The Journal of Chemical Physics. 129: 214707. PMID 19063575 DOI: 10.1063/1.3010881  0.258
1990 Holzman TF, Chung CC, Edalji R, Egan DA, Gubbins EJ, Rueter A, Howard G, Yang LK, Pederson TM, Krafft GA, Wang GT. Recombinant human prorenin from CHO cells: Expression and purification Journal of Protein Chemistry. 9: 663-672. PMID 1963533 DOI: 10.1007/Bf01024761  0.251
1991 Holzman TF, Chung CC, Edalji R, Egan DA, Martin M, Gubbins EJ, Krafft GA, Wang GT, Thomas AM, Rosenberg SH, Hutchins C. Characterization of recombinant human renin: Kinetics, pH-stability, and peptidomimetic inhibitor binding Journal of Protein Chemistry. 10: 553-563. PMID 1799412 DOI: 10.1007/Bf01025483  0.248
1997 Rockwell NC, Wang GT, Krafft GA, Fuller RS. Internally consistent libraries of fluorogenic substrates demonstrate that Kex2 protease specificity is generated by multiple mechanisms. Biochemistry. 36: 1912-7. PMID 9048578 DOI: 10.1021/Bi961779L  0.244
1999 Komano H, Rockwell N, Wang GT, Krafft GA, Fuller RS. Purification and characterization of the yeast glycosylphosphatidylinositol-anchored, monobasic-specific aspartyl protease yapsin 2 (Mkc7p). The Journal of Biological Chemistry. 274: 24431-7. PMID 10446224 DOI: 10.1074/jbc.274.34.24431  0.229
2007 Krafft GA. O2-05-03: Stable trimeric A-beta peptides: Potential vaccine immunogens to prevent ADDL-triggered memory deficits Alzheimer's & Dementia. 3: S196-S196. DOI: 10.1016/j.jalz.2007.04.019  0.21
1994 Krafft GA. Research and development challenges for Alzheimer's disease drug discovery Neurobiology of Aging. 15. PMID 7700463  0.197
1997 Brown ER, Barlow AK, Bodovitz S, Finch CE, Krafft GA, Klein WK. Binding of toxic aoligomers to neuronal cell surface proteins Faseb Journal. 11: A974.  0.15
1988 Walling EA, Krafft GA, Ware BR. Actin assembly activity of cytochalasins and cytochalasin analogs assayed using fluorescence photobleaching recovery Archives of Biochemistry and Biophysics. 264: 321-332. PMID 3395126 DOI: 10.1016/0003-9861(88)90600-5  0.12
1990 Matayoshi ED, Wang GT, Krafft GA, Erickson J. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer Science. 247: 954-958. PMID 2106161  0.119
1993 Wang GT, Chung CC, Holzman TF, Krafft GA. A continuous fluorescence assay of renin activity Analytical Biochemistry. 210: 351-359. PMID 8512070 DOI: 10.1006/abio.1993.1207  0.117
1992 Liger P, Krafft GA, Neuffer D. A bunching scheme for FEL applications at CEBAF Nuclear Inst. and Methods in Physics Research, A. 318: 290-294. DOI: 10.1016/0168-9002(92)91068-K  0.091
1992 Zlemnicka-Merchant B, Aran JM, Plagemann PGW, Krafft GA. Effects of chemical modification of nitrobenzylthioinosine on its binding to high-affinity membrane binding sites and inhibition of nucleoside transport Biochemical Pharmacology. 44: 1577-1583. PMID 1417982 DOI: 10.1016/0006-2952(92)90475-X  0.09
1999 Krafft GA. Short pulse synchrotron light from Jefferson Lab's nuclear physics accelerator Proceedings of the Ieee Particle Accelerator Conference. 4: 2448-2449.  0.08
1995 Wang GT, Li S, Wideburg N, Krafft GA, Kempf DJ. Synthetic chemical diversity: Solid phase synthesis of libraries of C2 symmetric inhibitors of HIV protease containing diamino diol and diamino alcohol cores Journal of Medicinal Chemistry. 38: 2995-3002. PMID 7636862  0.078
1994 Krafft GA, Wang GT. Synthetic approaches to continuous assays of retroviral proteases Methods in Enzymology. 241: 70-86. PMID 7854193  0.076
2003 Hoffstaetter GH, Barstow B, Bazarov IV, Belomestnykh S, Bilderback D, Gruner S, Liepe M, Padamsee H, Sagan D, Shemelin V, Sinclair C, Talman R, Tigner M, Veshcherevich V, Krafft GA, et al. The Cornell ERL prototype project Proceedings of the Ieee Particle Accelerator Conference. 1: 192-194.  0.075
2003 Bilderback DH, Bazarov IV, Finkelstein K, Gruner SM, Padamsee HS, Sinclair CK, Shen Q, Talman R, Tigner M, Krafft GA, Merminga L. Energy-recovery linac project at Cornell University. Journal of Synchrotron Radiation. 10: 346-8. PMID 12944617 DOI: 10.1107/S090904950301392X  0.074
2011 Ahmed S, Yunn B, Dolph J, Satogata T, Krafft GA. Study of electron cloud for MEIC Ipac 2011 - 2nd International Particle Accelerator Conference. 817-819.  0.072
1995 Legg R, Douglas D, Krafft GA, Saulter Q. Location and correction of 60 hz in the CEBAF injector Proceedings of the Ieee Particle Accelerator Conference. 3: 1873-1875.  0.071
1999 Piot P, Krafft GA, Jordan K, Grippo A, Song J. Performance of the electron beam diagnostics at Jefferson Lab's high power free electron laser Proceedings of the Ieee Particle Accelerator Conference. 3: 2229-2231.  0.071
1998 Lebedev VA, Bickley M, Bisognano J, Schaffner S, van Zeijts J, Krafft GA, Tiefenback M, Watson WA, Yunn B. Linear optics correction in the CEBAF accelerator Proceedings of the Ieee Particle Accelerator Conference. 2: 2128-2130.  0.068
2001 Leemann CW, Douglas DR, Krafft GA. The continuous electron beam accelerator facility: CEBAF at the jefferson laboratory Annual Review of Nuclear and Particle Science. 51: 413-450. DOI: 10.1146/annurev.nucl.51.101701.132327  0.067
1998 Lebedev VA, Bickley M, Schaffner S, Van Zeijts J, Krafft GA, Watson WA. Correction of dispersion and the betatron functions in the CEBAF accelerator Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 408: 373-379. DOI: 10.1016/S0168-9002(98)00198-3  0.066
2012 Ahmed S, Krafft GA, Deitrick K, De Silva SU, Delayen JR, Spata M, Tiefenback M, Hofler A, Beard K. Beam dynamics studies for transverse electromagnetic mode type rf deflectors Physical Review Special Topics - Accelerators and Beams. 15. DOI: 10.1103/Physrevstab.15.022001  0.065
1982 Chakravarty PK, Krafft GA, Katzenellenbogen JA. Haloenol lactones: enzyme-activated irreversible inactivators for serine proteases. Inactivation of alpha-chymotrypsin Journal of Biological Chemistry. 257: 610-612. PMID 7054169  0.064
1989 Krafft GA, Bisognano JJ. On using a superconducting linac to drive a short wavelength FEL . 1256-1258.  0.061
2006 Krafft GA. Performance achievements and challenges for fels based on energy recovered linacs 28th International Free Electron Laser Conference, Fel 2006. 252-256.  0.061
1994 Wang GT, Lane B, Fesik SW, Petros A, Luly J, Krafft GA. Synthesis and FKBP binding of small molecule mimics of the tricarbonyl region of FK506 Bioorganic and Medicinal Chemistry Letters. 4: 1161-1166. DOI: 10.1016/S0960-894X(01)80248-1  0.06
2001 Bazarov IV, Krafft GA, Merminga L. Linac optics for energy recovery Linac Proceedings of the Ieee Particle Accelerator Conference. 5: 3347-3349.  0.06
1998 Piot P, Song J, Li R, Krafft GA, Kehne D, Jordan K, Feldl E, Denard JC. Multislit transverse-emittance diagnostic for space-charge-dominated electron beams Proceedings of the Ieee Particle Accelerator Conference. 2: 2204-2206.  0.059
2007 Krafft GA. High brightness beam applications: Energy recovered linacs International Journal of Modern Physics A. 22: 3852-3863. DOI: 10.1142/S0217751X07037470  0.059
1981 Krafft GA, Katzenellenbogen JA. Synthesis of halo enol lactones. Mechanism-based inactivators of serine proteases Journal of the American Chemical Society. 103: 5459-5466.  0.058
1985 Krafft GA, Kim CH, Smith L. The lbl neutralized beam focusing experiment Ieee Transactions On Nuclear Science. 32: 2486-2488. DOI: 10.1109/TNS.1985.4333955  0.057
1998 Hardy D, Tang J, Legg R, Tiefenback M, Crofford M, Krafft GA. Automated path length and M56 measurements at Jefferson Lab Proceedings of the Ieee Particle Accelerator Conference. 2: 2265-2267.  0.057
2003 Merminga L, Douglas DR, Krafft GA. High-Current Energy-Recovering Electron Linacs Annual Review of Nuclear and Particle Science. 53: 387-429. DOI: 10.1146/annurev.nucl.53.041002.110456  0.056
2012 Ahmed S, Wissmann M, Mammosser J, Spata M, Hovater C, Krafft GA, Delayen JR. High power test of rf separator for 12 gev upgrade of cebaf at jefferson lab Ipac 2012 - International Particle Accelerator Conference 2012. 4032-4034.  0.056
2005 Benesch J, Bogacz A, Chao Y, Freyberger A, Grames J, Harwood L, Kazimi R, Krafft GA, Merminga L, Spata M, Tiefenback M, Wiseman M, Yunn B, Zhang Y. Beam physics for the 12 GeV CEBAF Upgrade project Proceedings of the Ieee Particle Accelerator Conference. 2005: 1482-1484. DOI: 10.1109/PAC.2005.1590807  0.055
2008 Kazimi R, Freyberger AP, Hovater C, Krafft GA, Marhauser F, Plawski TE, Reece CE, Sekutowicz J, Tennant C, Tiefenback MG, Wang H. Observation and mitigation of multipass BBU in CEBAF Epac 2008 - Contributions to the Proceedings. 2722-2724.  0.055
2011 Spata M, Krafft GA. Dual AC dipole excitation for the measurement of magnetic multipole strength from beam position monitor data Ipac 2011 - 2nd International Particle Accelerator Conference. 2865-2867.  0.055
1998 Krafft GA. Use of Jefferson Lab's high average power FEL as a Thomson backscatter X-ray source Proceedings of the Ieee Particle Accelerator Conference. 1: 739-741.  0.054
1998 Krafft GA, Jordan K, Kehne D, Benson S, Denard J, Feldl E, Piot P, Song J, Ursic R. Electron-beam diagnostics for Jefferson Lab's high power free electron laser Proceedings of the Ieee Particle Accelerator Conference. 1: 912-914.  0.054
2005 Kazimi R, Benesch JF, Chao Y, Grames JM, Krafft GA, Tiefenback M, Yunn BC, Zhang Y. Injection options for 12 GEV CEBAF upgrade Proceedings of the Ieee Particle Accelerator Conference. 2005: 2911-2913. DOI: 10.1109/PAC.2005.1591311  0.053
2012 Ahmed S, Yunn B, Krafft GA. Impedance budget for crab cavity in MEIC electron ring Ipac 2012 - International Particle Accelerator Conference 2012. 3153-3155.  0.053
1993 Merminga L, Bisognano JJ, Hovater C, Krafft GA, Simrock SN, Kubo K. Operation of the CEBAF linac with high beam loading Proceedings of the Ieee Particle Accelerator Conference. 5: 3515-3517.  0.053
2004 Krafft GA. Compact high-power terahertz radiation source Physical Review Special Topics - Accelerators and Beams. 7: 55-59. DOI: 10.1103/PhysRevSTAB.7.060704  0.052
2006 Freyberger AP, Krafft GA. Summary report on synchronization, diagnostics and instrumentation Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 557: 370-373. DOI: 10.1016/j.nima.2005.10.100  0.052
2001 Merminga L, Campisi IE, Douglas DR, Krafft GA, Preble J, Yunn BC. High average current effects in energy recovery LINACs Proceedings of the Ieee Particle Accelerator Conference. 1: 173-175.  0.051
2012 Ahmed S, Yunn B, Dolph J, Satogata T, Krafft GA. Computational modeling of electron cloud for meic Ipac 2012 - International Particle Accelerator Conference 2012. 1383-1385.  0.05
1982 Krafft GA, Mark JWK. Modification of electron beam ion source instability by longitudinal kinetic effects Nuclear Instruments and Methods in Physics Research. 198: 193-195. DOI: 10.1016/0167-5087(82)90255-1  0.05
2009 Krafft GA. Energy recovered linacs Proceedings of the 24th Linear Accelerator Conference, Linac 2008. 688-692.  0.05
1991 Neil GR, Bisognano JJ, Dylla HF, Krafft GA, Leemann CW, Sinclair CK, Yunn B. FEL design using the CEBAF linac Conference Record of 1991 Ieee Particle Accelerator Conference. 2745-2747. DOI: 10.1016/0168-9002(92)91053-C  0.05
1999 Campisi IE, Douglas D, Hovater C, Krafft GA, Merminga L, Yunn BC. Beam current limitations in the Jefferson Lab FEL: Simulations and analysis of proposed beam breakup experiments Proceedings of the Ieee Particle Accelerator Conference. 2: 1177-1179.  0.049
1982 Krafft GA, Reich MF, Katzenellenbogen JA. Synthesis of 14C-labeled 10,11-epoxyfarnesyl diazoacetate, a potential photoaffinity labeling reagent for insect juvenile hormone binding proteins Journal of Labelled Compounds and Radiopharmaceuticals. 19: 591-596. DOI: 10.1002/Jlcr.2580190413  0.049
1988 Cummings RT, DiZio JP, Krafft GA. Photoactivable fluorophores. 2. Synthesis and photoactivation of functionalized 3-aroyl-2-(2-furyl)-chromones Tetrahedron Letters. 29: 69-72. DOI: 10.1016/0040-4039(88)80018-2  0.048
1993 Krafft GA, Bisognano JJ, Crofford MT, Hovater JC, Merminga L, Simrock SN, Witherspoon SD, Kubo K. Energy vernier system for CEBAF Proceedings of the Ieee Particle Accelerator Conference. 3: 2364-2366.  0.047
1990 Heifets SA, Krafft GA, Fripp M. On asymmetric collisions with large disruption parameters Nuclear Inst. and Methods in Physics Research, A. 295: 286-290. DOI: 10.1016/0168-9002(90)90704-A  0.047
2013 Bogacz SA, Krafft GA, Morozov VS, Roblin YR. Jemmrla - electron model of a muon RLA with multi-pass arcs Ipac 2013: Proceedings of the 4th International Particle Accelerator Conference. 2085-2087.  0.046
1993 Simrock SN, Kazimi R, Krafft GA, Merminga L, Ninan L, Witherspoon S. Phasing schemes for the CEBAF cavities Proceedings of the Ieee Particle Accelerator Conference. 1: 599-601.  0.046
1999 Benson S, Biallas G, Bohn CL, Campisi IE, Douglas D, Evans R, Hill R, Jordan K, Krafft GA, Li R, Merminga L, Neil GR, Piot P, Preble J, Shinn M. First results on energy recovery in the Jefferson Lab IRFEL Proceedings of the Ieee Particle Accelerator Conference. 4: 2456-2458.  0.046
1995 Chowdhary M, Krafft GA, Shoaee H, Simrock SN, Watson WA. Prototype fast feedback system for energy lock at CEBAF Proceedings of the Ieee Particle Accelerator Conference. 4: 2417-2419.  0.045
1991 Krafft GA, Fripp M, Bisognano JJ. Emittance growth in TESLA Conference Record of 1991 Ieee Particle Accelerator Conference. 2073-2075.  0.044
2007 Priebe G, Laundy D, Jones LB, Diakun GP, Jamison SP, Holder DJ, Malton SP, Phillips PJ, MacDonald MA, Smith SL, Hirs GJ, Krafft GA, Seddon EA. Inverse Compton Backscattering Source driven by the multi 10 TW-Laser installed at Daresbury Proceedings of Spie - the International Society For Optical Engineering. 6702. DOI: 10.1117/12.739294  0.044
1995 Kazimi R, Dunham B, Krafft GA, Legg R, Liang C, Sinclair C, Mammosser J. Precision intercomparison of beam current monitors at CEBAF Proceedings of the Ieee Particle Accelerator Conference. 4: 2610-2612.  0.044
1993 Sereno NS, Cardman LS, Krafft GA, Sinclair CK, Bisognano JJ. Studies of multipass beam breakup and energy recovery using the CEBAF injector linac Proceedings of the Ieee Particle Accelerator Conference. 5: 3246-3248.  0.044
2003 Piot P, Douglas DR, Krafft GA. Longitudinal phase space manipulation in energy recovering linac-driven free-electron lasers Physical Review Special Topics - Accelerators and Beams. 6: 25-35. DOI: 10.1103/Physrevstab.6.030702  0.043
2001 Siggins T, Sinclair C, Bohn C, Bullard D, Douglas D, Grippo A, Gubeli J, Krafft GA, Yunn B. Performance of a DC GaAs photocathode gun for the Jefferson lab FEL Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 475: 549-553. DOI: 10.1016/S0168-9002(01)01596-0  0.043
1993 Tiefenback MG, Krafft GA. Compensation of RF-induced energy spread in the CEBAF injector chopping system Proceedings of the Ieee Particle Accelerator Conference. 1: 426-428.  0.043
1990 Wang GT, Matayoshi E, Jan Huffaker H, Krafft GA. Design and synthesis of new fluorogenic HIV protease substrates based on resonance energy transfer Tetrahedron Letters. 31: 6493-6496. DOI: 10.1016/S0040-4039(00)97099-0  0.042
1998 Krafft GA. Analyzing measurements of nonlinear transfer functions with Tschebyshev polynomials Proceedings of the Ieee Particle Accelerator Conference. 2: 2268-2270.  0.041
2008 Priebe G, Laundy D, MacDonald MA, Diakun GP, Jamison SP, Jones LB, Holder DJ, Smith SL, Phillips PJ, Fell BD, Sheehy B, Naumova N, Sokolov IV, Ter-Avetisyan S, Spohr K, ... Krafft GA, et al. Inverse Compton backscattering source driven by the multi-10 TW laser installed at Daresbury Laser and Particle Beams. 26: 649-660. DOI: 10.1017/S0263034608000700  0.04
1998 Wang DX, Krafft GA. Measuring longitudinal distribution and bunch length of femtosecond bunches with RF zero-phasing method Proceedings of the Ieee Particle Accelerator Conference. 2: 2020-2022.  0.04
1988 Meinke PT, Krafft GA. Preparation and cycloaddition reactions of selenoketones Journal of the American Chemical Society. 110: 8679-8685.  0.04
1990 Krafft GA, Wang GT. Chapter 32. Catalytic Antibodies: A New Class of Designer Enzymes Annual Reports in Medicinal Chemistry. 25: 299-308. DOI: 10.1016/S0065-7743(08)60036-6  0.04
2005 Krafft GA, Doyuran A, Rosenzweig JB. Pulsed-laser nonlinear Thomson scattering for general scattering geometries. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 72: 056502. PMID 16383764 DOI: 10.1103/Physreve.72.056502  0.038
1998 Song J, Piot P, Legg R, Kehne D, Li R, Feldl E, Jordan K, Denard JC, Krafft GA, Neil GR, Bohn CL. Real-time transverse-emittance and phase-space monitor Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 407: 343-349. DOI: 10.1016/S0168-9002(98)00047-3  0.038
1990 MATAYOSHI E, WANG G, KRAFFT G, KEMPF D, CODACOVI L, ERICKSON J. A Rapid Fluorogenic Assay of HIV Protease Inhibitors Annals of the New York Academy of Sciences. 616: 566-568. DOI: 10.1111/j.1749-6632.1990.tb17895.x  0.038
1993 Chao Y, Crofford M, Dobeck N, Douglas D, Hofler A, Hovater C, Krafft GA, Legg R, Perry J, Price E, Suhring S, Tiefenback M, van Zeijts J. Commissioning and operation experience with the CEBAF recirculation arc beam transport system Proceedings of the Ieee Particle Accelerator Conference. 1: 587-589.  0.038
1988 Cummings RT, Krafft GA. Photoactivable fluorophores. 1. Synthesis and photoactivation of o-nitrobenzyl-quenched fluorescent carbamates Tetrahedron Letters. 29: 65-68. DOI: 10.1016/0040-4039(88)80017-0  0.037
1995 Krafft GA, Wang D, Price E, Feldl E. Coherent synchrotron radiation detector for a non-invasive subpicosecond bunch length monitor Proceedings of the Ieee Particle Accelerator Conference. 4: 2601-2603.  0.036
1993 Hofler AS, Bowling BA, Higgins CS, Kloeppel PK, Krafft GA, Mahoney KL. Performance of the CEBAF arc beam position monitors Proceedings of the Ieee Particle Accelerator Conference. 3: 2298-2300.  0.036
1985 Krafft GA, Meinke PT. Functionalization of furans via phenacyl sulfides Tetrahedron Letters. 26: 135-138. DOI: 10.1016/S0040-4039(00)61862-2  0.036
1987 Krafft GA, Bisognano JJ. TWO DIMENSIONAL SIMULATIONS OF MULTIPASS BEAM BREAKUP . 1356-1358.  0.036
2010 Priebe G, Laundy D, Phillips PJ, Graham DM, Jamison SP, Vassilev S, Seddon EA, Rosenzweig JB, Krafft GA, Heinzl T, Filippetto D, Williams O, Spohr KM, Ter-Avetisyan S, Schramm U, et al. First results from the Daresbury Compton backscattering X-ray source (COBALD) Proceedings of Spie - the International Society For Optical Engineering. 7805. DOI: 10.1117/12.859671  0.035
1990 Wang GT, Matayoshi E, Erickson JW, Krafft GA. Fluorogenic determination of structural requirements for HIV protease substrates Annals of the New York Academy of Sciences. 616: 617-619.  0.035
1988 CUMMINGS RT, DIZIO JP, KRAFFT GA. ChemInform Abstract: Photoactivable Fluorophores. Part 2. Synthesis and Photoactivation of Functionalized 3-Aroyl-2-(2-furyl)chromones (V), (VI), and (XI). Cheminform. 19. DOI: 10.1002/chin.198822204  0.035
2011 Benson S, Borland M, Douglas DR, Dowell D, Hernandez-Garcia C, Kayran D, Krafft GA, Legg R, Moog E, Obina T, Rimmer R, Yakimenko V. X-ray sources by energy recovered linacs and their needed R&D Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 637: 1-11. DOI: 10.1016/j.nima.2010.07.090  0.034
2011 Ahmed S, Derbenev Y, Morozov V, Castilla A, Krafft GA, Yunn B, De Silva SU, Delayen JR. CRAB crossing schemes and studies for electron ion collider Ipac 2011 - 2nd International Particle Accelerator Conference. 2115-2117.  0.034
2014 Terzić B, Hofler AS, Reeves CJ, Khan SA, Krafft GA, Benesch J, Freyberger A, Ranjan D. Simultaneous optimization of the cavity heat load and trip rates in linacs using a genetic algorithm Physical Review Special Topics - Accelerators and Beams. 17. DOI: 10.1103/Physrevstab.17.101003  0.033
1986 Krafft GA, Garcia EA, Guram A, O'Shaughnessy B, Xu X. Simplified cytochalasins. 1. Synthesis of versatile perhydroisoindolone intermediates Tetrahedron Letters. 27: 2691-2694. DOI: 10.1016/S0040-4039(00)84618-3  0.031
2012 Castilla A, Delayen JR, Krafft GA. Design of electron and ion crabbing cavities for an electron-ion collider Ipac 2012 - International Particle Accelerator Conference 2012. 2447-2449.  0.03
1982 Vedejs E, Arnost MJ, Eustache JM, Krafft GA. Model study for synthesis of the cytochalasin D cycloundecanone ring system Journal of Organic Chemistry. 47: 4384-4386.  0.03
2004 Krafft GA. Spectral distributions of thomson-scattered photons from high-intensity pulsed lasers Physical Review Letters. 92: 204802-1. DOI: 10.1103/PhysRevLett.92.204802  0.029
2014 Terzić B, Deitrick K, Hofler AS, Krafft GA. Narrow-band emission in Thomson sources operating in the high-field regime. Physical Review Letters. 112: 074801. PMID 24579606 DOI: 10.1103/PhysRevLett.112.074801  0.029
1986 Krafft GA, Meinke PT. Selenoaldehydes: Preparation and dienophilic reactivity Journal of the American Chemical Society. 108: 1314-1315.  0.028
1985 Krafft GA, Siddall TL. Stereospecific displacement of sulfur from chiral centers. activation via thiaphosphonium salts Tetrahedron Letters. 26: 4867-4870. DOI: 10.1016/S0040-4039(00)94972-4  0.026
1987 Meinke PT, Krafft GA, Spencer JT. Selenofluorenone: Synthesis and cycloaddition chemistry Tetrahedron Letters. 28: 3887-3890. DOI: 10.1016/S0040-4039(00)96411-6  0.025
1988 Krafft GA, Sutton WR, Cummings RT. Photoactivable fluorophores. 3. Synthesis and photoactivation of fluorogenic difunctionalized fluoresceins Journal of the American Chemical Society. 110: 301-303.  0.023
2012 Bogacz SA, Hutton AM, Krafft GA, Morozov VS, Roblin YR, Beard KB, Johnson RP. Scaled electron model of a dogbone muon rla with multi-pass arcs Ipac 2012 - International Particle Accelerator Conference 2012. 235-237.  0.023
1988 Meinke PT, Krafft GA. Synthesis and cycloaddition reactivity of selenoaldehydes Journal of the American Chemical Society. 110: 8671-8679.  0.021
2006 Krafft GA. Spontaneous radiation emission from short, high field strength magnetic devices Physical Review Special Topics - Accelerators and Beams. 9. DOI: 10.1103/PhysRevSTAB.9.010701  0.019
2006 Krafft GA, Bowling BA, Crofford MT, Hovater JC. Phase transfer measurements at the Jefferson Lab recirculated linacs Nuclear Instruments and Methods in Physics Research, Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 557: 314-317. DOI: 10.1016/j.nima.2005.10.092  0.019
2012 Pinayev I, Belomestnykh S, Bengtsson J, Ben-Zvi I, Elizarov A, Fedotov AV, Gassner DM, Hao Y, Kayran D, Litvinenko VN, Mahler G, Meng W, Roser T, Sheehy B, Than R, ... ... Krafft GA, et al. Status of proof-of-principle experiment for coherent electron cooling Ipac 2012 - International Particle Accelerator Conference 2012. 400-402.  0.016
1993 Bickley M, Bowling BA, Douglas D, Hofler A, Kewisch J, Krafft GA. Orbit correction implementation at CEBAF Proceedings of the Ieee Particle Accelerator Conference. 3: 1895-1897.  0.016
2001 Bazarov IV, Bilderback DH, Gruner SM, Padamsee HS, Talman R, Tigner M, Krafft GA, Merminga L, Sinclair CK. The energy recovery linac (ERL) as a driver for x-ray producing insertion devices Proceedings of the Ieee Particle Accelerator Conference. 1: 230-232.  0.015
1988 Meinke PT, Krafft GA, Guram A. Synthesis of selenocyanates via cyanoselenation of organocopper reagents Journal of Organic Chemistry. 53: 3632-3634.  0.015
1995 Krafft GA, Crofford M, Douglas DR, Harwood SL, Kazimi R, Legg R, Oren W, Tremblay K, Wang D. Measuring and adjusting the path length at CEBAF Proceedings of the Ieee Particle Accelerator Conference. 4: 2429-2431.  0.012
1985 Krafft GA, Meinke PT. Generation of thioaldehydes via fluoride induced elimination of α-silyldisulfides Tetrahedron Letters. 26: 1947-1950. DOI: 10.1016/S0040-4039(00)98348-5  0.011
1987 Meinke PT, Krafft GA. Regiochemical preferences in selenoaldehyde cycloadditions Tetrahedron Letters. 28: 5121-5124. DOI: 10.1016/S0040-4039(00)95607-7  0.01
1982 Vedejs E, Krafft GA. Cyclic sulfides in organic synthesis Tetrahedron. 38: 2857-2881. DOI: 10.1016/0040-4020(82)85013-8  0.01
Hide low-probability matches.